Thornburg Investment Management Inc. Buys New Shares in Stevanato Group S.p.A. (NYSE:STVN)

Thornburg Investment Management Inc. bought a new stake in Stevanato Group S.p.A. (NYSE:STVN) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 171,840 shares of the company’s stock, valued at approximately $4,690,000. Thornburg Investment Management Inc. owned 0.06% of Stevanato Group at the end of the most recent reporting period.

Other hedge funds have also recently made changes to their positions in the company. Trust Point Inc. acquired a new position in shares of Stevanato Group in the 4th quarter valued at $252,000. Yorktown Management & Research Co Inc acquired a new position in shares of Stevanato Group in the 4th quarter valued at $254,000. Riverbridge Partners LLC increased its position in shares of Stevanato Group by 78.1% in the 4th quarter. Riverbridge Partners LLC now owns 1,274,805 shares of the company’s stock valued at $34,789,000 after acquiring an additional 559,070 shares during the period. Raymond James & Associates increased its position in shares of Stevanato Group by 0.9% in the 3rd quarter. Raymond James & Associates now owns 197,316 shares of the company’s stock valued at $5,864,000 after acquiring an additional 1,806 shares during the period. Finally, Natixis Advisors L.P. increased its position in shares of Stevanato Group by 2.6% in the 3rd quarter. Natixis Advisors L.P. now owns 23,409 shares of the company’s stock valued at $696,000 after acquiring an additional 590 shares during the period.

Stevanato Group Trading Up 0.4 %

Shares of STVN stock traded up €0.08 ($0.09) during mid-day trading on Friday, hitting €20.99 ($22.57). 34,814 shares of the stock were exchanged, compared to its average volume of 426,273. The firm has a fifty day moving average of €28.05 and a 200 day moving average of €28.66. The company has a current ratio of 1.92, a quick ratio of 1.35 and a debt-to-equity ratio of 0.21. Stevanato Group S.p.A. has a 52-week low of €20.01 ($21.52) and a 52-week high of €36.30 ($39.03).

Stevanato Group (NYSE:STVN) last issued its quarterly earnings results on Thursday, May 9th. The company reported €0.09 ($0.10) earnings per share for the quarter, missing analysts’ consensus estimates of €0.12 ($0.13) by (€0.03) (($0.03)). The company had revenue of €256.24 million during the quarter, compared to analysts’ expectations of €261.28 million. Stevanato Group had a net margin of 12.57% and a return on equity of 12.61%. Analysts predict that Stevanato Group S.p.A. will post 0.55 EPS for the current fiscal year.

Analyst Ratings Changes

STVN has been the topic of several research reports. Morgan Stanley reaffirmed an “equal weight” rating and set a $30.00 price target on shares of Stevanato Group in a research report on Monday, April 22nd. BNP Paribas initiated coverage on Stevanato Group in a research report on Monday, April 22nd. They set an “outperform” rating on the stock. Finally, Stephens reaffirmed an “overweight” rating and set a $38.00 price target on shares of Stevanato Group in a research report on Monday, March 25th. Two research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of €34.29 ($36.87).

Stevanato Group Profile

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.